BIXLENVO Trademark

Trademark Overview


On Tuesday, November 28, 2023, a trademark application was filed for BIXLENVO with the United States Patent and Trademark Office. The USPTO has given the BIXLENVO trademark a serial number of 98288717. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, March 4, 2025. This trademark is owned by Gilead Sciences Ireland UC. The BIXLENVO trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
bixlenvo

General Information


Serial Number98288717
Word MarkBIXLENVO
Filing DateTuesday, November 28, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, March 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2025

Trademark Statements


Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events


Event DateEvent Description
Wednesday, June 26, 2024ASSIGNED TO EXAMINER
Thursday, June 27, 2024LETTER OF SUSPENSION E-MAILED
Thursday, June 27, 2024SUSPENSION LETTER WRITTEN
Friday, December 1, 2023NEW APPLICATION ENTERED
Monday, January 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 27, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, September 27, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, November 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 1, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 7, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 7, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 22, 2024ASSIGNED TO LIE
Wednesday, December 11, 2024APPROVED FOR PUB - PRINCIPAL REGISTER